Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014, Article ID 781780, 5 pages
http://dx.doi.org/10.1155/2014/781780
Clinical Study

Xuezhikang Therapy Increases miR-33 Expression in Patients with Low HDL-C Levels

1Department of Geriatric Cardiology, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing 100853, China
2National Center for Pharmaceutical Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China

Received 12 June 2013; Revised 1 November 2013; Accepted 18 November 2013; Published 23 January 2014

Academic Editor: Holly Soares

Copyright © 2014 Ruihua Cao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. Gordon, J. L. Probstfield, R. J. Garrison et al., “High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies,” Circulation, vol. 79, no. 1, pp. 8–15, 1989. View at Google Scholar · View at Scopus
  2. S. E. Nissen, J.-C. Tardif, S. J. Nicholls et al., “Effect of torcetrapib on the progression of coronary atherosclerosis,” The New England Journal of Medicine, vol. 356, no. 13, pp. 1304–1316, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. W. E. Boden, J. L. Probstfield, T. Anderson et al., “Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy,” The New England Journal of Medicine, vol. 365, no. 24, pp. 2255–2267, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Fernández-Hernando, Y. Suárez, K. J. Rayner, and K. J. Moore, “MicroRNAs in lipid metabolism,” Current Opinion in Lipidology, vol. 22, no. 2, pp. 86–92, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. K. J. Rayner, Y. Suárez, A. Dávalos et al., “MiR-33 contributes to the regulation of cholesterol homeostasis,” Science, vol. 328, no. 5985, pp. 1570–1573, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. K. J. Rayner, C. C. Esau, F. N. Hussain et al., “Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides,” Nature, vol. 478, no. 7369, pp. 404–407, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. K. J. Rayner, F. J. Sheedy, C. C. Esau et al., “Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis,” Journal of Clinical Investigation, vol. 121, no. 7, pp. 2921–2931, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Fichtlscherer, A. M. Zeiher, and S. Dimmeler, “Circulating MicroRNAs: biomarkers or mediators of cardiovascular diseases?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 11, pp. 2383–2390, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Lu, W. Kou, B. Du et al., “Effect of xuezhikang, an extract from red yeast chinese rice, on coronary events in a Chinese population with previous myocardial infarction,” American Journal of Cardiology, vol. 101, no. 12, pp. 1689–1693, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J.-J. Li, S.-S. Hu, C.-H. Fang et al., “Effects of Xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with stable angina,” Clinica Chimica Acta, vol. 352, no. 1-2, pp. 217–224, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. E. M. Small and E. N. Olson, “Pervasive roles of microRNAs in cardiovascular biology,” Nature, vol. 469, no. 7330, pp. 336–342, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. I. A. Qureshi and M. F. Mehler, “The emerging role of epigenetics in stroke: II. RNA regulatory circuitry,” Archives of Neurology, vol. 67, no. 12, pp. 1435–1441, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. P. S. Mitchell, R. K. Parkin, E. M. Kroh et al., “Circulating microRNAs as stable blood-based markers for cancer detection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10513–10518, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. D'Alessandra, P. Devanna, F. Limana et al., “Circulating microRNAs are new and sensitive biomarkers of myocardial infarction,” European Heart Journal, vol. 31, no. 22, pp. 2765–2773, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Zampetaki, S. Kiechl, I. Drozdov et al., “Plasma MicroRNA profiling reveals loss of endothelial MiR-126 and other MicroRNAs in type 2 diabetes,” Circulation Research, vol. 107, no. 6, pp. 810–817, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Gui, Y. Tian, X. Wen et al., “Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies,” Clinical Science, vol. 120, no. 5, pp. 183–193, 2011. View at Publisher · View at Google Scholar · View at Scopus